Biomarkers in Emergency Medicine



According to the National Institutes of Health (NIH) Biomarkers Working Group, a biological marker (biomarker) is ‘a characteristic that is objectively measured and evaluated as an indicator of normal biological processes, pathogenic processes, or pharmacologic responses to a therapeutic intervention [1]’. In Emergency Medicine, most of the biomarker research has been concentrated in the field of cardiology, sepsis and renal failure, due to the significance of early detection and interventions.


Acute Coronary Syndrome Cardiac Troponin Lactate Clearance Urinary NGAL Mild Head Injury 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


  1. 1.
    Biomarkers Definitions Working Group. Biomarkers and surrogate endpoints: preferred definitions and conceptual framework. Clin Pharmacol Ther. 2001;69(3):89–95.CrossRefGoogle Scholar
  2. 2.
    Newby, et al. ACCF 2012 expert consensus document on practical clinical considerations in the interpretation of troponin elevations, a report of the American College of Cardiology Foundation task force on clinical expert consensus documents. JACC. 2012;60(23):2427–63.CrossRefPubMedGoogle Scholar
  3. 3.
    Morrow DA, Cannon CP, Jesse RL, et al. National academy of clinical biochemistry laboratory medicine practice guidelines: clinical characteristics and utilization of biochemical markers in acute coronary syndromes. Clin Chem. 2007;53:552–74.CrossRefPubMedGoogle Scholar
  4. 4.
    Anderson JL, Adams CD, Antman EM, Bridges CR, Califf RM, Casey Jr DE, et al. 2012 ACCF/AHA focused update incorporated into the guideline for the management of patients with unstable angina/non–ST-elevation myocardial infarction: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol. 2013;61:e179–347Google Scholar
  5. 5.
    Diercks DB, Peacock WF, Hollander JE, Singer AJ, Birkhahn R, Shapiro N, et al. Diagnostic accuracy of a point-of-care troponin I assay for acute myocardial infarction within 3 hours after presentation in early presenters to the emergency department with chest pain. Am Heart J. 2012;163:74–80.e4.CrossRefPubMedGoogle Scholar
  6. 6.
    Maisel AS, Clopton P, Krishnaswamy P, Novak RM, McCord J, Hollander JE, et al. Impact of age, race, and sex on the ability of B-type natriuretic peptide to aid in the emergency diagnosis of heart failure: results from the breathing not properly (BNP) multinational study. Am Heart J. 2004;147(6):1078–84.CrossRefPubMedGoogle Scholar
  7. 7.
    McMurray JJ, Adamopoulos S, Anker SD. ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: the task force for the diagnosis and treatment of acute and chronic heart failure 2012 of the European Society of Cardiology. Eur Heart J. 2012;33:1787–847.CrossRefPubMedGoogle Scholar
  8. 8.
    Geersing GJ, Erkens PM, Lucassen WA, Büller HR, Cate HT, Hoes AW, et al. Safe exclusion of pulmonary embolism using the wells rule and qualitative D-dimer testing in primary care: prospective cohort study. BMJ. 2012;345:e6564.CrossRefPubMedPubMedCentralGoogle Scholar
  9. 9.
    Wells PS, Anderson DR, Rodger M, et al. Derivation of a simple clinical model to categorize patients’ probability of pulmonary embolism: increasing the model utility with the SimpliRED D-dimer. Thromb Haemost. 2000;83:418.Google Scholar
  10. 10.
    Turedi S, Gunduz A, Mentese A, Topbas M, Karahan SC, Yeniocak S, et al. The value of ischemia-modified albumin compared with d-dimer in the diagnosis of pulmonary embolism. Respir Res. 2008;9:49.CrossRefPubMedPubMedCentralGoogle Scholar
  11. 11.
    Konstantinides SV, Torbicki A, Agnelli G, Danchin N, Fitzmaurice D, Galie N. ESC guidelines on the diagnosis and management of pulmonary embolism: the task force for the diagnosis and management of acute pulmonary embolism of the European Society of Cardiology (ESC). Eur Heart J. 2014;35:3033–80.CrossRefPubMedGoogle Scholar
  12. 12.
    Pierrakos C, Vincent JL. Sepsis biomarkers: a review. Crit Care. 2010;14(1):R15.CrossRefPubMedPubMedCentralGoogle Scholar
  13. 13.
    Cho SY, Choi JH. Biomarkers of sepsis. Infect Chemother. 2014;46(1):1–12.CrossRefPubMedPubMedCentralGoogle Scholar
  14. 14.
    Póvoa P, Coelho L, Almeida E, Fernandes A, Mealha R, Moreira P, Sabino H. C-reactive protein as a marker of infection in critically ill patients. Clin Microbiol Infect. 2005;11:101–8.CrossRefPubMedGoogle Scholar
  15. 15.
    Simon L, Gauvin F, Amre DK, Saint-Louis P, Lacroix J. Serum procalcitonin and C-reactive protein levels as markers of bacterial infection: a systematic review and meta-analysis. Clin Infect Dis. 2004;39:206–17.CrossRefPubMedGoogle Scholar
  16. 16.
    Kopterides P, Siempos II, Tsangaris I, Tsantes A, Armaganidis A. Procalcitonin-guided algorithms of antibiotic therapy in the intensive care unit: a systematic review and meta-analysis of randomized controlled trials. Crit Care Med. 2010;38:2229–41.CrossRefPubMedGoogle Scholar
  17. 17.
    Shapiro NI, Howell MD, Talmor D, Nathanson LA, Lisbon A, Wolfe RE, Weiss JW. Serum lactate as a predictor of mortality in emergency department patients with infection. Ann Emerg Med. 2005;45:524–8.CrossRefPubMedGoogle Scholar
  18. 18.
    Mikkelsen ME, Miltiades AN, Gaieski DF, et al. Serum lactate is associated with mortality in severe sepsis independent of organ failure or shock. Crit Care Med. 2009;37:1670–7.CrossRefPubMedGoogle Scholar
  19. 19.
    Nguyen HB, Rivers EP, Knoblich BP, Jacobsen G, Muzzin A, Ressler JA, Tomlanovich MC. Early lactate clearance is associated with improved outcome in severe sepsis and septic shock. Crit Care Med. 2004;32:1637–42.CrossRefPubMedGoogle Scholar
  20. 20.
    Mishra J, Mori K, Ma Q, Kelly C, Yang J, Mitsnefes M, et al. Amelioration of ischemic acute renal injury by neutrophil gelatinase-associated lipocalin. J Am Soc Nephrol. 2004;15(12):3073–82.CrossRefPubMedGoogle Scholar
  21. 21.
    Hirsch R, Dent C, Pfriem H, Allen J, Beekman 3rd RH, Ma Q, et al. NGAL is an early predictive biomarker of contrast-induced nephropathy in children. Pediatr Nephrol. 2007;22(12):2089–95.CrossRefPubMedGoogle Scholar
  22. 22.
    Calcagnile O, Unden L, Unden J. Clinical validation of S100B use in management of mild head injury. BMC Emerg Med. 2012;12:13.CrossRefPubMedPubMedCentralGoogle Scholar
  23. 23.
    Kratz A, Ferraro M, Sluss PM, Lewandrowski KB. Normal reference laboratory values. N Engl J Med. 2004;351:1548–63.CrossRefPubMedGoogle Scholar

Copyright information

© Springer India 2016

Authors and Affiliations

  1. 1.Department of Emergency MedicineKerala Institute of Medical SciencesTrivandrumIndia

Personalised recommendations